Evotec-Bristol Myers Squibb Partnership Gets Second FDA IND Acceptance
Evotec said its protein degradation collaboration with Bristol Myers Squibb received a second FDA investigational new drug acceptance.
Evotec said its protein degradation collaboration with Bristol Myers Squibb received a second FDA investigational new drug acceptance.